241 related articles for article (PubMed ID: 20974656)
21. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
22. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.
Gu D; Ge J; Du W; Xue F; Chen Z; Zhao H; Zhou Z; Xu J; Liu P; Zhao Q; Zhang L; Yang R
Autoimmunity; 2009; 42(8):692-8. PubMed ID: 19824872
[TBL] [Abstract][Full Text] [Related]
23. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
[TBL] [Abstract][Full Text] [Related]
24. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
[TBL] [Abstract][Full Text] [Related]
25. Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis.
Marín-Rosales M; Palafox-Sánchez CA; Franco-Topete RA; Carrillo-Ballesteros FJ; Cruz A; Salazar-Camarena DC; Muñoz-Valle JF; Ramos-Solano F
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614872
[TBL] [Abstract][Full Text] [Related]
26. Expression of BAFF and BR3 in patients with systemic lupus erythematosus.
Duan JH; Jiang Y; Mu H; Tang ZQ
Braz J Med Biol Res; 2016 Mar; 49(3):. PubMed ID: 26840704
[TBL] [Abstract][Full Text] [Related]
27. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
[TBL] [Abstract][Full Text] [Related]
28. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
29. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Hoi AY; Slavin L; Godsell JD; Kitching AR; Harris J; Nelson CL; Jenkins AJ; Chrysostomou A; Hibbs ML; Kerr PG; Rischmueller M; Mackay F; Morand EF
Lupus; 2018 Nov; 27(13):2029-2040. PubMed ID: 30301439
[TBL] [Abstract][Full Text] [Related]
30. Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers.
Aguirre-Valencia D; Ríos-Serna LJ; Posso-Osorio I; Naranjo-Escobar J; López D; Bedoya-Joaqui V; Nieto-Aristizábal I; Castro AM; Díaz-Ordoñez L; Navarro EP; Barrera MC; Echeverri A; Cañas CA; Tobón GJ
J Transl Autoimmun; 2020; 3():100027. PubMed ID: 32743512
[TBL] [Abstract][Full Text] [Related]
31. [BAFF level in bone marrow and expression of BAFF receptor on B cells in multiple myeloma patients].
Zhou ZH; Zhang L; Pan QY; Huang BH; Zheng D; Liu JR; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1131-4. PubMed ID: 23114133
[TBL] [Abstract][Full Text] [Related]
32. Intrarenal production of B-cell survival factors in human lupus nephritis.
Neusser MA; Lindenmeyer MT; Edenhofer I; Gaiser S; Kretzler M; Regele H; Segerer S; Cohen CD
Mod Pathol; 2011 Jan; 24(1):98-107. PubMed ID: 20890272
[TBL] [Abstract][Full Text] [Related]
33. Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
Kryštůfková O; Barbasso Helmers S; Venalis P; Malmström V; Lindroos E; Vencovský J; Lundberg IE
Arthritis Res Ther; 2014 Oct; 16(5):454. PubMed ID: 25301447
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of BAFF and its receptors in discoid lupus erythematosus patients.
Chong BF; Tseng LC; Kim A; Miller RT; Yancey KB; Hosler GA
J Dermatol Sci; 2014 Mar; 73(3):216-24. PubMed ID: 24315762
[TBL] [Abstract][Full Text] [Related]
35. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
36. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
37. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
38. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
39. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
40. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
